Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
9.68
-0.19 (-1.93%)
Jul 15, 2026, 4:00 PM EDT - Market closed
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $812.59 million as of July 15, 2026. Its market cap has increased by 13.47% in one year.
Market Cap
812.59M
Enterprise Value
655.29M
1-Year Change
13.47%
Ranking
Category
Stock Price
$9.68
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $812.59M, an increase of 73.81%. That is a compound annual growth rate of 7.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 812.59M | 6.57% |
| Dec 31, 2025 | 762.47M | -18.18% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 875.90M |
| Phathom Pharmaceuticals | 866.98M |
| Design Therapeutics | 865.34M |
| Faeth Therapeutics | 859.98M |
| Odyssey Therapeutics | 843.13M |
| Tenax Therapeutics | 816.45M |
| CytomX Therapeutics | 805.50M |
| Oculis Holding AG | 794.10M |